First Affiliated Hospital Xi'an Jiaotong University
Clinical trials sponsored by First Affiliated Hospital Xi'an Jiaotong University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Heart signal test could spot valve disease faster Results expected Sep 2026 (estimated)
- Bile acid pill may shield against statin blood sugar side effect Results expected Nov 2026 (estimated)
- New CMV prevention drug could be safer for kidney transplant patients Results expected Nov 2026 (estimated)
- Can we predict psoriasis relapse after biologics? a new study digs into the clues. Results expected Dec 2026 (estimated)
- Blood fat clues could flag hidden heart rhythm risk Results expected Jan 2027 (estimated)
-
Viruses vs. superbugs: new hope for skin infections?
Disease control By invitation onlyThis study tests a mixture of viruses called phages, which naturally kill bacteria, for treating skin infections that don't respond to antibiotics. Researchers will enroll 150 adults with infected wounds and compare the phage treatment to a placebo or standard care. The goal is t…
Early phase 1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can we predict psoriasis relapse after biologics? a new study digs into the clues.
Knowledge-focused OngoingThis study investigates why some people with plaque psoriasis experience a relapse after treatment with biologic drugs, while others do not. Researchers will compare patients who relapsed with those who did not, looking at factors like age, lifestyle, lab results, and treatment h…
Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC